NEPH (Nephros) Short Interest


NEPH Nephros Inc NEPH
63 GF Score
Price $3.35
GF Value $2.87
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Nephros Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

NEPH vs MLSS, HBIO, FEMY: Short Interest Comparison

For the Medical Instruments & Supplies subindustry, Nephros's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nephros Short Interest vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nephros's Short Interest distribution charts can be found below:

* The bar in red indicates where Nephros's Short Interest falls into.


NEPH
63GF Score
Nephros Inc NEPH
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Nephros (NEPH) Overvalued in 2026?

Based on GuruFocus' analysis, Nephros stock appears to be overvalued. The current stock price of $3.35 is trading 16.7% above its estimated GF Value™ of $2.87. GuruFocus considers Nephros to be Modestly Overvalued.

Key valuation signals for NEPH:

  • Short Interest:
  • GF Value™: $2.87 vs. price of $3.35 (16.7% above fair value)
  • GF Score™: 63/100 with 5 warning signs

No single metric tells the full story. See the NEPH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nephros Business Description

Other Exchanges NPJP:Germany
Address 380 Lackawanna Place, South Orange, NJ, USA, 07079
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of revenue from product sales and a small amount from royalty revenue and other revenues.
63GF Score

Get the complete analysis for NEPH

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.35
Price
$2.87
GF Value